We build software to enable pharmaceutical labs to discover new drugs more quickly. Collective Scientific LLC provides novel small molecule drug candidates for cancer protein targets and rare diseases in under one week. Through the use of cloud-based distributed systems, proprietary algorithms, and AI modules, our system derives novel small molecules for binding pockets with a known crystal structure. We identify the most promising of these candidates to provide our clients with a summarized report. Drug discovery laboratories can take advantage of our candidate identification services to maintain a full drug pipeline without additional training, software licenses, or IT infrastructure costs.